BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8735294)

  • 1. Long-term follow-up of women with borderline ovarian tumors.
    Kehoe S; Powell J
    Int J Gynaecol Obstet; 1996 May; 53(2):139-43. PubMed ID: 8735294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
    Zuna RE; Behrens A
    J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period.
    Akeson M; Zetterqvist BM; Dahllöf K; Jakobsen AM; Brännström M; Horvath G
    Int J Gynecol Cancer; 2008; 18(3):453-9. PubMed ID: 18476948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases.
    Bostwick DG; Tazelaar HD; Ballon SC; Hendrickson MR; Kempson RL
    Cancer; 1986 Nov; 58(9):2052-65. PubMed ID: 3756820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in women with borderline ovarian tumors: a population-based survey of borderline ovarian tumors in Sweden 1960-2007.
    Kalapotharakos G; Högberg T; Bergfeldt K; Borgfeldt C
    Acta Obstet Gynecol Scand; 2016 Apr; 95(4):473-9. PubMed ID: 26714557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma.
    Hannibal CG; Vang R; Junge J; Frederiksen K; Kurman RJ; Kjaer SK
    Gynecol Oncol; 2017 Jan; 144(1):174-180. PubMed ID: 27836204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
    Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
    Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and survival of borderline ovarian tumors in Rajavithi Hospital between 1979-2006 A.D.
    Sornsukolrat S; Tuipae S
    J Med Assoc Thai; 2012 Sep; 95(9):1141-8. PubMed ID: 23140030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borderline Ovarian Tumors: Fifteen Years' Experience at a Scottish Tertiary Cancer Center.
    May J; Skorupskaite K; Congiu M; Ghaoui N; Walker GA; Fegan S; Martin CW; O'Donnell RL
    Int J Gynecol Cancer; 2018 Nov; 28(9):1683-1691. PubMed ID: 30365457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
    Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
    J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and prognostic inflection points among long-term survivors of advanced epithelial ovarian cancer.
    Son JH; Kong TW; Paek J; Song KH; Chang SJ; Ryu HS
    Int J Gynaecol Obstet; 2017 Dec; 139(3):352-357. PubMed ID: 28857180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors.
    Ren J; Peng Z; Yang K
    Gynecol Oncol; 2008 Aug; 110(2):162-7. PubMed ID: 18495223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
    Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
    Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less extensive surgery compared to extensive surgery: survival seems similar in young women with adult ovarian granulosa cell tumor.
    Lauszus FF; Petersen AC; Neumann G; Cleemann L; Rosgaard A; Jørgensen A; Vandborg M; Jakobsen A
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():61-6. PubMed ID: 24698496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk borderline ovarian tumors: analysis of clinicopathological features and prognostic impact of different follow-up strategies.
    Lorusso D; Ratti M; Ditto A; Raspagliesi F
    Oncology; 2014; 87(3):183-92. PubMed ID: 25033912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.